
|Videos|April 26, 2022
EGFR Exon 20–Positive NSCLC: Future Directions in Care
Author(s)Zofia Piotrowska, MD, MHS
Before closing out her discussion on novel therapy for EGFR exon 20–positive NSCLC, Zofia Piotrowska, MD, shares her hopes for future developments in care.
Advertisement
Case: A 59-Year-Old Female with Lung Cancer
Initial presentation
- BC is a 59 y/o Asian female who presents to her physician complaining of shortness of breath, fatigue, and persistent right- sided neck pain.
- BC believes she is experiencing neck pain because of her new sleeping pillow.
- Since her last examination 6 months ago, BC has lost close to 10 lbs. BC has not changed her eating habits or style.
- PMH: Hypercholesterolemia (controlled)
- SMH: no history of smoking; drinks socially
- FH: she lives with her partner and 2 dogs; mother passed away from ovarian cancer 3 years ago.
- PE: LLL auscultation reveals decreased breath sounds visible bruising
Clinical workup
- Current Labs:
- CBC panel: Normal
- Liver function/Renal function: Normal
- CT Chest: LLL primary, mediastinal LNs; bone metastases
- Diagnosis: Stage IV adenocarcinoma
- MRI brain is negative for brain metastases
- CT scan of abdomen and pelvis shows additional bone metastases
- Weight: 120 lbs (54.5 kg)
- Biopsy of mediastinal lymph nodes shows stage 4 lung adenocarcinoma
- PD-L1 55%
Treatment
- NGS has been ordered and the results are pending.
- Patient initiated on a chemotherapy doublet.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Tinostamustine Orphan Drug Designation for Malignant Gliomas
2
Behind the FDA’s Elimination of REMS Program for CAR T-Cell Therapies
3
FDA Fast Tracks Bispecific ADC AVZO-1418 for EGFR-Mutated Pretreated NSCLC
4
A 25-Year Snapshot of Survival With Metastatic Breast Cancer and Brain Metastases
5







































